Original Research

Overexpression of CD300A inhibits progression of NSCLC through downregulating Wnt/β-catenin pathway

Tang Z, Cai H, Wang R, Cui Y

OncoTargets and Therapy 2018, 11:8875-8883

Published Date: 7 December 2018